|
FY2025
12 months to Dec 31, 2025
|
FY2024
8 months to Dec 31, 2024
|
|
|---|---|---|
| OPERATING ACTIVITIES: | ||
| Net increase in net assets resulting from operations | ||
| Adjustments to reconcile net increase in net assets resulting from operations to net cash used in operating activities: | ||
| Net accretion of investments | ||
| Purchases of investments | ||
| Amortization of deferred financing costs | ||
| Amortization of offering costs | ||
| Change in deferred tax liability, net | ||
| Net change in unrealized (gain) / loss on investments | ||
| Net change in unrealized (gain) / loss on derivatives | ||
| Realized loss on investments | ||
| Return of capital from investments | ||
| Proceeds from repayments or sales of investments | ||
| Changes in operating assets and liabilities: | ||
| Management fees payable | ||
| Capital gains incentive fee payable | ||
| Income based incentive fee payable | ||
| Accrued expenses | ||
| Prepaid expenses | ||
| Other assets | ||
| Interest payable | ||
| Unsettled trades payable | ||
| Net cash used in operating activities | ||
| FINANCING ACTIVITIES: | ||
| Net proceeds from issuance of common stock | ||
| Borrowings from term loans | ||
| Repayments of term loans | ||
| Payments for deferred financing costs | ||
| Repurchased shares, net of early repurchase deduction | ||
| Distributions to shareholders | ||
| Net cash provided by financing activities | ||
| Net change in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash, beginning of period | ||
| Cash, cash equivalents and restricted cash, end of period | ||
| Supplemental Information: | ||
| Interest paid during the period | ||
| Distribution declared and payable during the period | ||
| Non-cash financing activity: | ||
| Offering costs | ||
| Distribution reinvested |
Loading...
